Roivant Sciences Ltd (NASDAQ:ROIV) shares, rose in value on Wednesday, January 22, with the stock price down by -0.98% to the previous day’s close as strong demand from buyers drove the stock to $11.16.
Actively observing the price movement in the last trading, the stock closed the session at $11.27, falling within a range of $11.08 and $11.37. The value of beta (5-year monthly) was 1.243 whereas the PE ratio was 1.97 over 12-month period. Referring to stock’s 52-week performance, its high was $13.06, and the low was $9.69. On the whole, ROIV has fluctuated by -4.53% over the past month.
With the market capitalization of Roivant Sciences Ltd currently standing at about $8.12 billion, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.75M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ROIV’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ROIV currently trading nearly -2.22% and -5.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.65, while the 7-day volatility ratio is showing 2.51% which for the 30-day chart, stands at 2.92%. Furthermore, Roivant Sciences Ltd (ROIV)’s beta value is 1.25, and its average true range (ATR) is 0.34.
A comparison of Roivant Sciences Ltd (ROIV) with its peers suggests the former has fared considerably weaker in the market. ROIV showed an intraday change of -0.98% in last session, and over the past year, it grew by 7.83%%.
Data on historical trading for Roivant Sciences Ltd (NASDAQ:ROIV) indicates that the trading volumes over the past 10 days have averaged 4.93 and over the past 3 months, they’ve averaged 4.75 million. According to company’s latest data on outstanding shares, there are 733.33 million shares outstanding.
Nearly 38.44% of Roivant Sciences Ltd’s shares belong to company insiders and institutional investors own 67.67% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 43.5 million shares as on 2024-12-31, resulting in a short ratio of 8.95. According to the data, the short interest in Roivant Sciences Ltd (ROIV) stood at 796.00 of shares outstanding as of 2024-12-31; the number of short shares registered in 2024-11-29 reached 47.81 million. The stock has fallen by -5.66% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ROIV stock heading into the next quarter.
